Dr. Mark Gonzalgo is Professor and Chair of Urology, University of Miami Miller School of Medicine and Executive Director of Perioperative Surgical Services, University of Miami Health System. He also serves as director of the urologic oncology fellowship program. Dr. Gonzalgo is a urologic oncologist with expertise in robotic surgical approaches for the treatment of prostate, kidney, and bladder cancers. He received his undergraduate degree with honors from the University of California at Berkeley and completed medical and graduate school at the USC Keck School of Medicine. Dr. Gonzalgo completed his general surgery and urology training at Johns Hopkins and a fellowship in urologic oncology at Memorial Sloan-Kettering Cancer Center.
Dr. Gonzalgo is a recognized expert in DNA methylation and is particularly interested in developing new diagnostic and therapeutic approaches for cancer detection and treatment. He has carried out pioneering research on the molecular biology and early detection of urologic cancer and has published extensively on the scientific and clinical aspects of these diseases. Dr. Gonzalgo is a member of the American Association of Genitourinary Surgeons (AAGUS) and has been recognized as a Top Doctor by US News & World Report. He is Chair of the Office of Education for the American Urological Association and is an emeritus member of the scientific advisory board of the Bladder Cancer Advocacy Network (BCAN).
Education & Training
Education
1999: University of Southern California Keck School of Medicine
MD
1999: Keck School of Medicine of the USC
PhD
Publications
Disclaimer: The information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, please use this link to inform our data team. Your feedback is greatly appreciated and helps us improve the quality of our content.
